Timing and severity of skin-related adverse events in a phase II trial of sorafenib (BAY43-9006) in patients with advanced thyroid cancer.
Raya D. Terry
Research Funding - Bayer
Stephen Michael Keefe
Research Funding - Bayer
Carolyn Marie Grande
Research Funding - Bayer
Larisa Zifchak
Research Funding - Bayer
Marcia S. Brose
Consultant or Advisory Role - Bayer Schering Pharma; Bayer/Onyx
Honoraria - Bayer Schering Pharma
Research Funding - Bayer Schering Pharma; Bayer/Onyx